Pooled Results of Three Annual Cohorts From an Observational Prospective Study Describing Brentuximab Vedotin Use in Routine Practice in France for Hodgkin Lymphoma: Interim Analysis
Hematological Oncology - United Kingdom
doi 10.1002/hon.170_2631
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2019
Authors
Publisher
Wiley